Evidence map›Paper›PMID 40802230›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

VirClia

Jordi Tortosa-Carreres, Carmen Lloret-Sos, Jose Miguel Sahuquillo-Arce, Marta Garrido-Jareño, Ana Fornals-López, Gabriela Pérez-Cataldo, Amparo Alba-Redono, María Luisa Martínez-Triguero, Cristina Aguado-Codina, Rosa María Pascual-Costa and 2 more

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jordi Tortosa-CarreresLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain. jorditc95@outlook.com.ORCID http://orcid.org/0000-0002-4622-2173
Carmen Lloret-SosMicrobiology Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Jose Miguel Sahuquillo-ArceMicrobiology Department, Hospital General de Fuerteventura Virgen de la Peña, Carretera del Aeropuerto, Km 1, Puerto del Rosario, Fuerteventura, 35600, Spain. wadjur@hotmail.com.ORCID http://orcid.org/0000-0002-0139-8271
Marta Garrido-JareñoMicrobiology Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.ORCID http://orcid.org/0000-0001-6164-5521
Ana Fornals-LópezMicrobiology Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Gabriela Pérez-CataldoMicrobiology Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Amparo Alba-RedonoLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
María Luisa Martínez-TrigueroLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Cristina Aguado-CodinaLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Rosa María Pascual-CostaLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Begoña Laiz-MarroLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.
Jose Luis López-HontangasLaboratory Department, Hospital Univeritari i Politècnic la Fe, Av Fernando Abril Martorell 106, València, 46026, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVirClia

objectiveTo assess the diagnostic performance of VirClia

methodsA retrospective study was conducted using two independent datasets from routine clinical samples tested simultaneously by IFA and VirClia

resultsApplying gray zone thresholds-using the manufacturer's upper cut-off (1.1) and a sensitivity-driven lower limit-yielded estimated IFA reductions of 56% for B. henselae IgG, 42% for IgM, and 79% for C. burnetii (combined phases). FP results for C. burnetii were significantly associated with extractable nuclear antigens and older age.

conclusionVirClia

Indexed as

Antibodies, BacterialBartonella henselaeCat-Scratch DiseaseCoxiella burnetiiLuminescent MeasurementsQ FeverAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansImmunoglobulin GImmunoglobulin MAntibodies, BacterialImmunoglobulin GImmunoglobulin MAutomationBartonella HenselaeCLIACoxiella burnetiiCross-reactivity

Identifiers

PMID40802230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.